#1 Review Article: Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region
👨⚕️👩⚕️ Milan J. Anadkat et al
👉 https://t.co/5lV8vbpIY5
@fedgrosso@Rrkotecha@hornezd#ThoracicOncology
New #Mesothelioma#clinicaltrial led by @QMULBartsTheLon & involving NCARD's Prof Anna Nowak shows a new metabolism-based treatment that extends survival rates for patients with non-epithelioid subtype. A vital step in ongoing #CancerResearch.
Read more: https://t.co/WeGKTx2A50
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advan... https://t.co/7ZAlu7b8lS
#mesothelioma
and now we have to work hard on predictive biomarkers
💪💪💪
In this episode of #LungCancerConsidered, host @StephenVLiu leads a discussion of current strategies to treat Mesothelioma w/2 experts: @dean_fennell from the University of Leicester & Dr. Federica Grosso from Azienda Ospedaliera Alessandria. Listen: https://t.co/WkAvsMOMYM #LCSM
È una grande gioia condividere con tutti voi che mi è appena giunto il diploma della Onorificenza di Ufficiale dell'ordine "Al merito della Repubblica Italiana" che il Presidente Sergio Mattarella mi ha conferito.
#InternationalWomensDay: To achieve a #GenderBalance in the field of #oncology, ESMO W4O develops local initiatives, conducts research, and shares information concerning equal opportunities and career fulfillment.
👉https://t.co/6o99Sgr4NS
@Piuchagarrido
Learn the importance of seeking #cancer care at a top #mesothelioma center — one with surgeons, oncologists and radiologists who have experience with the disease. https://t.co/tRGQtXGJuS
Amianto, l’allarme impunità di Guariniello: “Ci sono i morti, ma nessuno è colpevole. Io provai a cambiare le cose, tocca al Parlamento” https://t.co/IrhKpgGewj via @fattoquotidiano